613 related articles for article (PubMed ID: 9017005)
21. Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation.
Mhatre M; McAndrew T; Carpenter C; Burk RD; Einstein MH; Herold BC
Sex Transm Dis; 2012 Aug; 39(8):591-7. PubMed ID: 22801340
[TBL] [Abstract][Full Text] [Related]
22. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.
Hallez S; Simon P; Maudoux F; Doyen J; Noël JC; Beliard A; Capelle X; Buxant F; Fayt I; Lagrost AC; Hubert P; Gerday C; Burny A; Boniver J; Foidart JM; Delvenne P; Jacobs N
Cancer Immunol Immunother; 2004 Jul; 53(7):642-50. PubMed ID: 14985860
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
25. Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.
Bais AG; Beckmann I; Ewing PC; Eijkemans MJ; Meijer CJ; Snijders PJ; Helmerhorst TJ
Mediators Inflamm; 2007; 2007():24147. PubMed ID: 18288269
[TBL] [Abstract][Full Text] [Related]
26. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
[TBL] [Abstract][Full Text] [Related]
27. Cytokines profiles in cervical mucosa in patients with cervical high-risk human papillomavirus infection.
Long DL; Song HL; Qu PP
J Infect Dev Ctries; 2021 May; 15(5):719-725. PubMed ID: 34106897
[TBL] [Abstract][Full Text] [Related]
28. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
Sarkar AK; Tortolero-Luna G; Follen M; Sastry KJ
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
[TBL] [Abstract][Full Text] [Related]
30. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
Tsukui T; Hildesheim A; Schiffman MH; Lucci J; Contois D; Lawler P; Rush BB; Lorincz AT; Corrigan A; Burk RD; Qu W; Marshall MA; Mann D; Carrington M; Clerici M; Shearer GM; Carbone DP; Scott DR; Houghten RA; Berzofsky JA
Cancer Res; 1996 Sep; 56(17):3967-74. PubMed ID: 8752165
[TBL] [Abstract][Full Text] [Related]
32. Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β -511 is associated with development of cervical carcinoma.
Dutta S; Chakraborty C; Mandal RK; Basu P; Biswas J; Roychoudhury S; Panda CK
Cancer Immunol Immunother; 2015 Jul; 64(7):843-51. PubMed ID: 25893807
[TBL] [Abstract][Full Text] [Related]
33. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
[TBL] [Abstract][Full Text] [Related]
34. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women.
Branca M; Delfino A; Rossi E; Giacomini G; Leoncini L; Riti MG; Morosini PL
Eur J Gynaecol Oncol; 1995; 16(5):410-7. PubMed ID: 8549609
[TBL] [Abstract][Full Text] [Related]
35. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
36. Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years.
Paaso A; Koskimaa HM; Welters MJ; Grénman S; Syrjänen K; van der Burg SH; Syrjänen S
J Transl Med; 2015 May; 13():163. PubMed ID: 25990808
[TBL] [Abstract][Full Text] [Related]
37. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
38. [Incidence of HPV and CIN in HIV positive women].
Zarcone R; Cardone G; Bellini P; Carfora E; Fortuna G; Raucci F
Minerva Ginecol; 1995 Nov; 47(11):477-80. PubMed ID: 8820392
[TBL] [Abstract][Full Text] [Related]
39. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
Gill DK; Bible JM; Biswas C; Kell B; Best JM; Punchard NA; Cason J
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
[TBL] [Abstract][Full Text] [Related]
40. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]